UK markets closed

Relief Therapeutics Holding AG (0QKQ.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.0285-0.0005 (-1.72%)
At close: 05:51PM GMT
Full screen
Previous close0.0290
Open0.0285
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0285 - 0.0291
52-week range0.0285 - 0.0291
Volume116,690
Avg. volumeN/A
Market cap180,674
Beta (5Y monthly)-13.94
PE ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

    Relief Therapeutics Holding SA / Key word(s): MiscellaneousAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival 21.11.2022 / 07:00 CET/CESTAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film FestivalGeneva, Switzerland, November 21, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTD) (“Relief”), a Swiss, commercial-stage biophar

  • EQS Group

    Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission

    Relief Therapeutics Holding SA / Key word(s): Miscellaneous16-Nov-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission Geneva, Switzerland, November 16, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTD) (“Relief”), announced today that it has filed Amen

  • EQS Group

    Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements

    Relief Therapeutics Holding SA / Key word(s): Miscellaneous14-Nov-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement AgreementsGeneva, Switzerland and Radnor, Pennsylvania, November 14, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTD) ("Relief"), and NRx Pharmaceuticals, Inc. (